Tomorrow Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: compounded semaglutide or tirzepatide by injection or drops, from a seller that names its pharmacies
Tomorrow's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Tomorrow is a self-pay telehealth service from Tomorrow Health LLC that offers compounded semaglutide and tirzepatide in three forms (weekly shots, lower-dose shots and under-the-tongue drops), plus brand Wegovy and Zepbound. It names its medical group, its two pharmacies and the lead physician's NPI. Paid monthly, compounded semaglutide is $199 and tirzepatide $299; the lower 'from' prices it shows are averages of a 3-month charge.
Is Tomorrow legit?
Yes. Tomorrow is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.1/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Tomorrow promo or coupon code?
We know of no promo or coupon code for Tomorrow. Its listed price is $199 a month. Coupon sites advertising "Tomorrow discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Tomorrow compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Tomorrow
CoreAge Rx
Best for: flat-priced compounded semaglutide at $79 a month, any dose
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Tomorrow at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Wegovy, Zepbound
- Starting price
- $199/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letters found
How Tomorrow scores
Six columns, each one computed from something Tomorrow has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
5.0/10$199/month is exactly the median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Tomorrow
Last checked October 2026- Checked the listed price across 6 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Tomorrow
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Tomorrow involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Tomorrow shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Tomorrow which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $199, tirzepatide $299. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Tomorrow serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Tomorrow
- Phone
- (855) 879-8679
- Tomorrow offers email support
Cancelling Tomorrow
Taken from the terms Tomorrow publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- No contract. Plans renew monthly or every 3 months, as you choose, until canceled at least 3 days before the next billing date
- Refund policy
- "All prescription sales are final." "Charges already processed are non-refundable, and we do not refund partially used subscription periods."
Medications Tomorrow lists
Tomorrow lists Wegovy, Ozempic, Zepbound, Mounjaro, compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
$199 billed monthly, or $549 billed every 3 months (the source of the $183 'from' price). Drug, needles, prescriber care and delivery are all in that price. A lower-dose microdose version with vitamin B12 is $149 a month or $399 every 3 months.
$299 billed monthly, or $819 billed every 3 months (the source of the $273 'from' price). A microdose version with vitamin B12 is $199 a month or $549 every 3 months.
Drops held under the tongue instead of an injection. $199 billed monthly or $549 every 3 months. The seller says there is no FDA-approved sublingual form of semaglutide.
$299 billed monthly or $819 every 3 months. The seller says there is no FDA-approved sublingual form of tirzepatide.
Wegovy at $1,699 billed monthly, with clinician care and shipping included. Ozempic is also listed at $1,399 a month, a diabetes drug without a weight-loss approval.
Zepbound at $1,399 billed monthly. Mounjaro, a diabetes drug, is listed at the same $1,399.
Check the price yourself before you pay
Every figure here was read off Tomorrow's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $199 a month, close to the $199 median for compounded semaglutide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Tomorrow
Against it
- Tirzepatide costs $299 a month, 20% above the $249 median for compounded tirzepatide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Tomorrow charges
Tomorrow charges $199/month.
- Compounded semaglutide: $199/month
- Compounded tirzepatide: $299/month
- Compounded semaglutide: $199/month
- Compounded tirzepatide: $299/month
- Wegovy: $1,699/month
- Zepbound: $1,399/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so Tomorrow's $199 lands mid-market. Price is unlikely to be the deciding factor.
Bodybuilding Health+ dispenses semaglutide and tirzepatide from $179/month, which makes it the fair comparison to run before you commit here.
What Tomorrow dispenses
Tomorrow prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. You can take the approved brand pen or the cheaper compounded preparation. What separates them is review: the approved product went through it, the compounded one did not, and that is the whole of the trade.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Tomorrow at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
Tomorrow tells you its price before you start the medical questionnaire. We found no FDA warning letters issued to Tomorrow. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Tomorrow will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You need insurance to cover the cost. Check whether Tomorrow bills your plan before you start.
It fits if
- injections are the thing keeping you from starting
Our read
Tomorrow lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. Belle Health is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Tomorrow's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Before you pay Tomorrow
Starting at $199 a month. Check today's price, then start the intake.
Where Tomorrow is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare Tomorrow head to head
The sellers closest to Tomorrow on medication and price.
Frequently Asked Questions
How to check Tomorrow yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Tomorrow review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Tomorrow's current pricing
Plans start at $199 a month. Whether you qualify is a clinician's decision, made after your intake.